News – Page 129 – Endpoints News

FDA approves Sun Pharma's JAK inhibitor Leqselvi for hair loss in adults

10 months ago

Westlake's non-opioid pain startup Latigo gets new leader; Ron Cooper lands next CEO gig at enGene

10 months ago

Updated: With cost-cutting underway, Bristol Myers raises guidance, touts Phase 3 win and scraps another

10 months ago

FDA advisors call for better studies of immunotherapy around lung cancer surgery, but give AstraZeneca a pass

10 months ago

EU panel follows FDA’s lead on Wegovy, recommending use to prevent cardiac events

10 months ago

Ipsen loses legal appeal over whether blockbuster cancer treatment is a drug or biologic

10 months ago

Taking advantage of recent successes, Roche will push obesity drugs faster, flirts with M&A

10 months ago

AbbVie beats expectations with smaller Humira slide — and big gains for next autoimmune blockbusters

10 months ago

AstraZeneca details ‘very ambitious’ strategy for early-stage obesity programs

10 months ago

Sanofi shelves four assets, including mid-stage dwarfism candidate

10 months ago

Galderma deprioritizes study for IL-31 drug; UCB stops work in rare encephalitis

10 months ago

AbbVie expects $8.7B Cerevel buy to close ‘as early as next week,’ new CEO says

10 months ago

Novo Nordisk considers another facility; Lonza’s new CEO shares his priorities

10 months ago

Manatt scoops up health tech experts Christina Farr and Tom Cassels

10 months ago

Sanofi eyes RSV antibody for its next blockbuster while Dupixent brings in record sales

10 months ago

Roche cuts two more TIGIT trials, plans accelerated timeline for obesity drugs

10 months ago

Updated: AstraZeneca says there’s ‘very limited’ impact on Farxiga after US drug pricing negotiations

10 months ago

BioMarin snags expanded Brineura label, now approved for all kids regardless of symptoms

10 months ago

Exclusive: After selling Mirati to BMS for nearly $5B, Chuck Baum lands at another ‘undruggable’ company

10 months ago

Ipsen pays Day One $111M upfront for ex-US rights to pediatric brain tumor drug

10 months ago

Argenx to retest Vyvgart in autoimmune platelet disease after failure last year

10 months ago

Viking to push obesity drug to Phase 3 in bid to reach market faster

10 months ago

Republican-led states can't intervene in case on abortion pill restrictions, appeals court says

10 months ago

US bankrolls a third of global Pandemic Fund. Can it get congressional support?

10 months ago

First page Previous page 126 127 128129130 131 132 Next page Last page